Pharma & Biotech

Jasper Therapeutics finds itself at the center of a growing legal crisis as multiple law firms investigate potential securities law...

Harvard Bioscience shares experienced a significant decline following the release of disappointing quarterly earnings, yet a deeper examination of the...

CervoMed is confronting a severe financial crisis that threatens its very existence. The biopharmaceutical company's latest quarterly report discloses staggering...

The survival of 23AndMe Holding Co. hangs by a thread as the company navigates Chapter 11 bankruptcy proceedings under its...

Rallybio has delivered a stunning financial turnaround that caught market observers by surprise. The biotechnology company reported a net profit...

Pluri Inc. finds itself at a pivotal moment as the biotechnology firm prepares to release quarterly results on Monday. With...

The landscape of American pharmacy retail has undergone a fundamental change as Walgreens Boots Alliance completes its transition to private...

The telehealth provider Hims & Hers finds itself at a critical juncture, presenting a complex financial picture where robust revenue...

Viking Therapeutics is generating significant attention in the biotech sector with new clinical findings for its experimental weight-loss treatment, VK2735....

In a surprising market development, shares of Crinetics Pharmaceuticals are experiencing notable gains despite the company reporting disappointing quarterly financial...